Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Array BioPharma presents new PTPN11 inhibitors

Oct. 22, 2020

Storm Therapeutics patents METTL3 inhibitors

Oct. 22, 2020

FDA grants full approval to Venclexta combinations for newly diagnosed AML

Oct. 21, 2020

Cardiff Oncology reports phase II results with onvansertib in mCRPC

Oct. 21, 2020

AstraZeneca discloses new PROTACs for cancer therapy

Oct. 21, 2020

PDAC subtypes point to targeting strategies

Oct. 21, 2020

New substudy evaluates Treadwell's CFI-400945 in metastatic CRPC

Oct. 20, 2020

Chinese researchers present new MAPK inhibitors

Oct. 20, 2020

Betta Pharmaceuticals patents EGFR mutant inhibitors

Oct. 20, 2020

Hinova Pharmaceuticals divulges new BRD4 and AR dual inhibitors

Oct. 20, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...